Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Mayo Clinic investigates stem cell coated fistula plug in cryptoglandular perianal fistulas

Jan. 15, 2016

LeafBio initiates phase I trial of MB-66 monoclonal antibody vaginal film

Jan. 14, 2016

Cepheid to collaborate with MedImmune and COMBACTE to develop bacterial pneumonia diagnostics

Jan. 14, 2016

Gilead submits NDA for tenofovir alafenamide for chronic HBV infection

Jan. 13, 2016

High-dose monovalent inactivated poliovirus type 2 vaccine is safe and immunogenic in infants

Jan. 12, 2016

Aridis reports promising phase I data on Aerucin

Jan. 11, 2016

Gilead reports topline data from phase III studies of tenofovir alafenamide in chronic HBV

Jan. 11, 2016

FDA grants priority review for sNDA for Viekira Pak in genotype 1b HCV and cirrhosis

Jan. 8, 2016

Paratek expects results from phase III trial of omadacycline in ABSSSI in mid-2016

Jan. 8, 2016

State University of New Jersey reports antibacterial compounds

Jan. 8, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.